VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure May 4, 2024 — 18:00
Chinese president’s upcoming visit to bring new hope to Serbia’s development: Vucic May 1, 2024 — 11:51
INMOTION Debuts Innovational 2-in-1 Self-balancing Vehicle E20 at Global Sources HK Show 2024 April 25, 2024 — 23:50